// March 13, 2024
Producing maternal health supplies in sub-Saharan Africa ...
Understanding the landscape to expand, strengthen, and diversify African-based manufacturing
Global Health
// June 24, 2024
Advancing regional manufacturing in Africa: Four key takeaways from the 77th World He...
Expanding regional manufacturing in Africa relies on capable suppliers and a predictable demand. Following the World Health Assembly, we explore four ways to advance medicines manufacturing on the continent. Read the blog.
// April 19, 2024
Procuring HIV/AIDS medicines from African producers...
Expanding regional manufacturing of HIV/AIDS tests and medicines from African producers will help bolster public health across the continent.
// December 19, 2024
Manufacturing pharmaceutical ingredients in Nigeria...
Poor-quality medical products are all too common in Africa, where substandard and falsified medicines kill nearly 500,000 people each year, according to the United Nations. The continent also has the highest prevalence of poor-quality medicines among low- and middle-income countries at 18.7 percent.
In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC), the national regulating authority for medical products, is prioritizing local production of medicines to ensure a safer supply of quality-assured medical products to protect patients and communities across the country and continent.
// July 02, 2024
Reflecting on results from four years fighting TB in the Kyrgyz Republic ...
In 2022, more than 8,000 people in the Kyrgyz Republic developed tuberculosis (TB), including
// May 24, 2023
World Vaccine Congress 2023: Spotlight shines on mRNA and viral vectored technology p...
Interest in innovative vaccines that use messenger ribonucleic acid (mRNA) and viral vectored technologies was among the key draws at this year’s World Vaccine Congress (WVC) on April 3-6 in Washington, D.C.
// March 07, 2023
Nitrosamine Impurities: Latest USP Tool Further Aids Understanding and Control...
USP has launched the newest tool in our suite of solutions to address the evolving nitrosamines crisis: the Nitrosamines Analytical Hub, a public, web-based repository of downloadable analytical procedures to test for nitrosamine impurities and related substances in pharmaceuticals.
// February 09, 2023
Africa’s growing vaccine capacity
Manufacturing products locally for more equitable pandemic responses
// October 07, 2022
Tackling medicine supply shortages starting with their ingredients ...
How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
Show 11 More